For those moaning about Novartis "ruining" Alcon, you fail to see that business as we knew it in ophthalmology was over. Patients were demanding generics, doctors had given up their authority and resolve to insist on name brand drugs, and large medical groups had started to shut down access to drug reps and their samples. The good old days (60s, 70s, 80s, 90s) were over, regardless if Novartis bought Alcon or not. Alcon and ophthalmology were just one of the last holds out to get affected by Big Healthcare.
The Industry Changed - Alcon was the last holdout
Aucun commentaire:
Enregistrer un commentaire